Editorial: Vaccination of Special Populations: Protecting the Vulnerable

Affiliations

• ¹ Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
• ² NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
• ³ Pediatric Immunopathology and Allergology Unit, Tor Vergata University Hospital, University of Rome "Tor Vergata", Rome, Italy.
• ⁴ Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain.
• ⁵ Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela (USC), Galicia, Spain.
• ⁶ Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBER-ES), Madrid, Spain.
• ⁷ Clinical Immunology and Vaccinology Unit, Academic Department of Pediatrics, Ospedale Pediatrico Bambino Gesù-IRCCS, Rome, Italy.
• ⁸ Chair of Pediatrics, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.